The short answer: Usually not on your own, and often not at all. Normal levels while you take levothyroxine mean the dose is working, not that your thyroid has healed. People whose hypothyroidism came from Hashimoto's, thyroid surgery, or radioactive iodine generally need it for life. Some people, especially those treated for temporary thyroiditis or mild subclinical hypothyroidism, can come off it safely under a clinician's supervision with repeat TSH tests.

Do normal thyroid levels mean you are cured?

No. Levothyroxine is a lab-made copy of T4, the main hormone your thyroid makes. A normal TSH on treatment tells you the pill is supplying the right amount. It says nothing about how much hormone your own gland can make without help.

The FDA-approved Synthroid label on DailyMed tells prescribers to explain that levothyroxine replaces a hormone the thyroid normally makes. It adds: "Generally, replacement therapy is to be taken for life." The American Thyroid Association (ATA) patient page on hypothyroidism says the same thing in plainer words: "Most people take thyroid medicine for life." It also notes that a problem caused by a virus or by pregnancy "may go away."

So the real question is not "are my levels normal?" It is "why did I start this medicine, and could that cause have resolved?" If you are unsure how TSH and free T4 fit together, our guide to thyroid blood tests walks through each one.

Which causes of hypothyroidism are usually permanent?

For most people on long-term levothyroxine, the cause is one that does not reverse.

  • Hashimoto's thyroiditis. The immune system slowly damages the thyroid. The ATA thyroiditis page says that in Hashimoto's, "hypothyroidism is usually permanent." Read more in our Hashimoto's thyroiditis guide.
  • Thyroid surgery. After removal of part or all of the gland for nodules, cancer, or Graves' disease, the ATA says your thyroid "may not make enough hormone afterward." With the whole gland gone, there is nothing left to recover.
  • Radioactive iodine or radiation. The ATA notes these treatments "can damage the thyroid." That damage is meant to be lasting when the goal is to treat an overactive gland.

People treated for thyroid cancer are a special case. Their dose may be set to keep TSH low on purpose, so stopping is a decision only their cancer team should make.

Which causes can be temporary?

Some forms of thyroiditis cause a hypothyroid phase that often fades on its own.

  • Postpartum thyroiditis. The ATA postpartum thyroiditis page says the hypothyroid phase typically starts 4 to 8 months after delivery. "Most women will regain normal thyroid function within 12-18 months." About 20% of those who become hypothyroid stay that way.
  • Subacute (painful) thyroiditis. The ATA says it resolves to normal function within 12 to 18 months in about 95% of patients, with a 5% chance of permanent hypothyroidism. In a 2026 Chinese follow-up study, 28 of 30 patients checked about 9 years after subacute thyroiditis were euthyroid, and 2 had subclinical hypothyroidism.
  • Silent (painless) thyroiditis. The ATA lists the same 12 to 18 month recovery window, with a 20% chance of permanent hypothyroidism.
  • Mild subclinical hypothyroidism. This means TSH is a little high while free T4 is normal. TSH can rise for a while after an illness or with some drugs, then settle. Our subclinical hypothyroidism article covers when treatment helps.

For thyroiditis, the ATA says that if thyroid hormone is started, it "should be continued for approximately 6-12 months and then reduced to see if thyroid hormone is required permanently."

What do studies on stopping levothyroxine show?

Several studies have tested stopping in selected patients. None were randomized trials, so the results carry real uncertainty.

  • 2021 meta-analysis. A systematic review in Thyroid pooled 17 observational studies with 1,103 patients. About a third (37.2%) stayed euthyroid after stopping. The split mattered: 35.6% of people first diagnosed with subclinical hypothyroidism stayed euthyroid, versus 11.8% of those with overt hypothyroidism. The authors rated the evidence low quality.
  • 2026 JAMA study in older adults. Ravensberg and colleagues enrolled 370 adults aged 60 or older at 58 Dutch general practices. All had a TSH under 10 mIU/L on a stable dose for at least a year. At 1 year, 95 (25.7%) were off levothyroxine with acceptable thyroid function. Among the 88 people on 50 mcg a day or less, 63.6% succeeded. Thyroid-related quality of life did not change in a clinically relevant way.
  • Greek cohorts. In a 2018 study of 291 people taking levothyroxine without a solid diagnosis, 60.8% stayed euthyroid 6 to 8 weeks after stopping. A 2025 follow-up of 802 similar patients found 23% became hypothyroid overall. Among those still normal at 4 months, only 7% became hypothyroid over up to 60 months.

The common thread: success is most likely when the original diagnosis was mild or never firmly made. It is least likely after overt hypothyroidism.

How is a supervised trial off levothyroxine done?

There is no single protocol that all guidelines endorse. A 2026 Endocrine Society journal review on deprescribing stresses a "structured, patient-centered, and closely supervised plan." The steps below reflect the published approaches, not a do-it-yourself plan.

  1. Review the original diagnosis. Your clinician looks at why treatment started, the TSH before treatment, antibodies, and any surgery or radioactive iodine history.
  2. Check for reasons not to try. Pregnancy or planning pregnancy is one. The Synthroid label says levothyroxine "should not be discontinued during pregnancy."
  3. Reduce or pause under a plan. The Dutch JAMA study used stepwise dose reductions set by the study protocol. The Greek studies stopped the drug outright. Your clinician picks the method and any dose changes.
  4. Retest TSH and free T4. The JAMA study tested at least 6 weeks after each reduction. The 2018 Greek study retested 6 to 8 weeks after stopping. Levothyroxine's half-life is 6 to 7 days in people with normal thyroid function (9 to 10 days in hypothyroidism), per the FDA label, so levels take weeks to settle.
  5. Keep checking. Hypothyroidism can come back months later, so follow-up tests continue after a successful stop.

For subclinical hypothyroidism, the 2013 European Thyroid Association guideline is direct. If treatment was started for symptoms, review the response 3 or 4 months after TSH reaches the normal range. "If there is no improvement in symptoms, L-thyroxine therapy should generally be stopped."

What are the risks of stopping on your own?

If your thyroid cannot make enough hormone, stopping brings hypothyroidism back. Because T4 clears slowly, symptoms may creep in over weeks rather than days. That delay can make it hard to link fatigue, cold intolerance, or weight change to the missed medicine. If you are not sure which symptoms to watch, the symptom.md site has a plain-language overview.

Other medicines can be affected too. The Synthroid label tells clinicians to monitor blood sugar closely when thyroid therapy is started, changed, or discontinued in people with diabetes. Thyroid status also changes how warfarin and digoxin work.

At the far end, untreated severe hypothyroidism can lead to myxedema coma. The FDA label calls it "a life-threatening emergency." That outcome is rare, but it is one reason clinicians do not advise stopping without a plan.

The bottom line

Normal levels on levothyroxine mean the dose fits, not that the problem is gone. Hashimoto's, thyroid removal, and radioactive iodine usually mean lifelong treatment. Postpartum, subacute, and silent thyroiditis, and some cases of mild subclinical hypothyroidism, can be temporary. Studies suggest roughly a quarter to a third of carefully chosen patients stay off it, with lower odds after overt hypothyroidism. If you think you no longer need it, ask your clinician about a planned trial with repeat TSH testing. Do not stop on your own.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Do not stop or change your thyroid medication without talking to your prescriber.